NICE puts premium device prices on trial
About
I’m Benedict Stanberry — I research, write, teach, speak and consult on the subjects of health economics, outcomes and management.
Today, in addition to establishing HEOR Institute, I am an independent health economics and outcomes research consultant — partnering with medical device and life sciences companies to develop the economic and clinical evidence that drives successful market access.
But I haven’t always been an HEOR specialist…
Featured research
Practice areas
Expertise
HEOR Strategy
HEOR strategy is the discipline of planning, sequencing and generating the evidence needed to support health technology assessment (HTA) or payer engagement. It determines what clinical and economic evidence is required, identifies what already exists and maps a structured pathway to address the gaps.
Expertise
Health Economic Modelling
Health economic modelling uses analytical frameworks to compare the costs and outcomes of different treatments and interventions. By synthesising clinical, epidemiological and cost data, economic models enable decision-makers to assess the value and affordability of a healthcare innovation.
Expertise
Evidence Review and Synthesis
Evidence review and synthesis is the systematic identification, appraisal and aggregation of published research on a defined clinical or economic question. It provides the evidential foundation on which health economic models, health technology assessment (HTA) submissions and market access strategies are built.
Expertise
Health Technology Assessment (HTA)
Health technology assessment (HTA) is the process by which the clinical- and cost-effectiveness of a new treatment or intervention, as well as its broader impact on patients and health systems, is evaluated to determine whether it represents sufficient value to justify adoption and funding.
Expertise
Value Communication
Value communication is the strategic process of translating complex clinical, economic and humanistic evidence into a clear, compelling and structured narrative that is tailored to the needs of specific healthcare decision-makers. It is a mission-critical activity that links evidence generation to successful market access.
Practice areas
HEOR Strategy
HEOR strategy is the discipline of planning, sequencing and generating the evidence needed to support health technology assessment (HTA) or payer engagement. It determines what clinical and economic evidence is required, identifies what already exists and maps a structured pathway to address the gaps.
Health Economic Modelling
Health economic modelling uses analytical frameworks to compare the costs and outcomes of different treatments and interventions. By synthesising clinical, epidemiological and cost data, economic models enable decision-makers to assess the value and affordability of a healthcare innovation.
Evidence Review and Synthesis
Evidence review and synthesis is the systematic identification, appraisal and aggregation of published research on a defined clinical or economic question. It provides the evidential foundation on which health economic models, health technology assessment (HTA) submissions and market access strategies are built.
Health Technology Assessment (HTA)
Health technology assessment (HTA) is the process by which the clinical- and cost-effectiveness of a new treatment or intervention, as well as its broader impact on patients and health systems, is evaluated to determine whether it represents sufficient value to justify adoption and funding.
Value Communication
Value communication is the strategic process of translating complex clinical, economic and humanistic evidence into a clear, compelling and structured narrative that is tailored to the needs of specific healthcare decision-makers. It is a mission-critical activity that links evidence generation to successful market access.